© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003

References 5300-5399

5300. Y. Yano, “Artificial flavin receptors: effects of hydrogen bonding on redox properties of a flavin mimic,” Antioxid. Redox Signal 3(October 2001):899-909.

5301. J. Chin, J. Oh, S.Y. Jon, S.H. Park, C. Walsdorff, B. Stranix, A. Ghoussoub, S.J. Lee, H.J. Chung, S.M. Park, K. Kim, “Tuning and dissecting electronic and steric effects in ammonium receptors: nonactin vs artificial receptors,” J. Am. Chem. Soc. 124(15 May 2002):5374-5379.

5302. A. Ojida, Y. Mito-Oka, M.A. Inoue, I. Hamachi, “First artificial receptors and chemosensors toward phosphorylated peptide in aqueous solution,” J. Am. Chem. Soc. 124(5 June 2002):6256-6258.

5303. I.A. Nicholls, “Towards the rational design of molecularly imprinted polymers,” J. Mol. Recognit. 11(Winter 1998):79-82.

5304. R. Norel, D. Petrey, H.J. Wolfson, R. Nussinov, “Examination of shape complementarity in docking of unbound proteins,” Proteins 36(15 August 1999):307-317.

5305. A.P. Singh, J.C. Latombe, D.L. Brutlag. “A motion planning approach to flexible ligand binding,” Proc. Int. Conf. Intell. Syst. Mol. Biol. (1999):252-261.

5306. H.J. Wolfson, R. Nussinov, “Geometrical docking algorithms. A practical approach,” Methods Mol. Biol. 143(2000):377-397; R. Nussinov, H.J. Wolfson, “Efficient computational algorithms for docking and for generating and matching a library of functional epitopes. II. Computer vision-based techniques for the generation and utilization of functional epitopes,” Comb. Chem. High Throughput Screen. 2(October 1999):261-269.

5307. M.L. Johnson, M. Straume, “Deriving complex ligand-binding formulas,” Methods Enzymol. 323(2000):155-167.

5308. I. Luque, E. Freire, “Structural stability of binding sites: consequences for binding affinity and allosteric effects,” Proteins 4(2000):63-71 (Suppl).

5309. D.A. Spivak, J. Campbell, “Systematic study of steric and spatial contributions to molecular recognition by non-covalent imprinted polymers,” Analyst 126(June 2001):793-797.

5310. L.Q. Gu, S. Cheley, H. Bayley, “Capture of a single molecule in a nanocavity,” Science 291(26 January 2001):636-640.

5311. A. Rachkov, N. Minoura, “Towards molecularly imprinted polymers selective to peptides and proteins. The epitope approach,” Biochim. Biophys. Acta 1544(12 January 2001):255-266; “Recognition of oxytocin and oxytocin-related peptides in aqueous media using a molecularly imprinted polymer synthesized by the epitope approach,” J. Chromatogr. A 889(11 August 2000):111-118.

5312. K. Mosbach, K. Haupt, “Some new developments and challenges in non-covalent molecular imprinting technology,” J. Mol. Recognit. 11(Winter 1998):62-68.

5313. A. Martin-Esteban, “Molecularly imprinted polymers: new molecular recognition materials for selective solid-phase extraction of organic compounds,” Fresenius J. Anal. Chem. 370(August 2001):795-802.

5314. A. Bossi, S.A. Piletsky, E.V. Piletska, P.G. Righetti, A.P. Turner, “Surface-grafted molecularly imprinted polymers for protein recognition,” Anal. Chem. 73(1 November 2001):5281-5286.

5315. P. Spegel, L. Schweitz, S. Nilsson, “Molecularly imprinted polymers,” Anal. Bioanal. Chem. 372(January 2002):37-38.

5316. Y. Lu, C. Li, X. Liu, W. Huang, “Molecular recognition through the exact placement of functional groups on non-covalent molecularly imprinted polymers,” J. Chromatogr. A 950(15 March 2002):89-97.

5317. L.I. Andersson, “Molecular imprinting: developments and applications in the analytical chemistry field,” J. Chromatogr. B Biomed. Sci. Appl. 745(4 August 2000):3-13.

5318. F. Lanza, B. Sellergren, “Molecularly imprinted extraction materials for highly selective sample cleanup and analyte enrichment,” Adv. Chromatogr. 41(2001):137-173.

5319. J. Jodlbauer, N.M. Maier, W. Lindner, “Towards ochratoxin A selective molecularly imprinted polymers for solid-phase extraction,” J. Chromatogr. A 945(1 February 2002):45-63.

5320. R.J. Ansell, D. Kriz, K. Mosbach, “Molecularly imprinted polymers for bioanalysis: chromatography, binding assays and biomimetic sensors,” Curr. Opin. Biotechnol. 7(1 February 1996):89-94.

5321. A.L. Jenkins, O.M. Uy, G.M. Murray, “Polymer-based lanthanide luminescent sensor for detection of the hydrolysis product of the nerve agent Soman in water,” Anal. Chem. 71(15 January 1999):373-378.

5322. K. Haupt, K. Mosbach, “Molecularly imprinted polymers and their use in biomimetic sensors,” Chem. Rev. 100(12 July 2000):2495-2504.

5323. H.S. Ji, S. McNiven, K.H. Lee, T. Saito, K. Ikebukuro, I. Karube, “Increasing the sensitivity of piezoelectric odour sensors based on molecularly imprinted polymers,” Biosens. Bioelectron. 15(October 2000):403-409.

5324. A.L. Jenkins, R. Yin, J.L. Jensen, “Molecularly imprinted polymer sensors for pesticide and insecticide detection in water,” Analyst 126(June 2001):798-802.

5325. N. Kirsch, J.P. Hart, D.J. Bird, R.W. Luxton, D.V. McCalley, “Towards the development of molecularly imprinted polymer based screen-printed sensors for metabolites of PAHs,” Analyst 126(November 2001):1936-1941.

5326. B. Sellergren, L.I. Andersson, “Application of imprinted synthetic polymers in binding assay development,” Methods 22(September 2000):92-106.

5327. L. Ye, Y. Yu, K. Mosbach, “Towards the development of molecularly imprinted artificial receptors for the screening of estrogenic chemicals,” Analyst 126(June 2001):760-765.

5328. L. Ye, O. Ramstrom, R.J. Ansell, M.O. Mansson, K. Mosbach, “Use of molecularly imprinted polymers in a biotransformation process,” Biotechnol. Bioeng. 64(20 September 1999):650-655.

5329. O. Ramstrom, K. Mosbach, “Synthesis and catalysis by molecularly imprinted materials,” Curr. Opin. Chem. Biol. 3(December 1999):759-764.

5330. O. Bruggemann, K. Haupt, L. Ye, E. Yilmaz, K. Mosbach, “New configurations and applications of molecularly imprinted polymers,” J. Chromatogr. A 889(11 August 2000):15-24.

5331. H. Miyazaki, K. Hayashi, “Effects of cyclic strain on the morphology and phagocytosis of macrophages,” Biomed. Mater. Eng. 11(2001):301-309.

5332. F.J. Alenghat, D.E. Ingber, “Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins,” Sci. STKE (12 February 2002):PE6; C.J. Meyer, F.J. Alenghat, P. Rim, J.H. Fong, B. Fabry, D.E. Ingber, “Mechanical control of cyclic AMP signalling and gene transcription through integrins,” Nat. Cell Biol. 2(September 2000):666-668; C.S. Chen, D.E. Ingber, “Tensegrity and mechanoregulation: from skeleton to cytoskeleton,” Osteoarthritis Cartilage 7(January 1999):81-94.

5333. N. Wang, K. Naruse, D. Stamenovic, J.J. Fredberg, S.M. Mijailovich, I.M. Tolic-Norrelykke, T. Polte, R. Mannix, D.E. Ingber, “Mechanical behavior in living cells consistent with the tensegrity model,” Proc. Natl. Acad. Sci. (USA) 98(3 July 2001):7765-7770; http://www.pnas.org/cgi/content/full/98/14/7765

5334. M.J. Sheehy, E.J. Yunis, R.M. Agostini Jr., F.B. Quintieri, D.Y. Leung, R.S. Geha, E.J. Yunis, “Morphology of human T lymphocyte clones,” Lab. Invest. 48(May 1983):549-555.

5335. C.B. Thompson, J.J. Ryan, D.G. Sieckmann, F.D. Finkelman, J.J. Mond, I. Scher, “A method for size separation of murine spleen cells using counterflow centrifugation,” J. Immunol. Methods 63(28 October 1983):299-307.

5336. D. Opstelten, D.G. Osmond, “Pre-B cells in mouse bone marrow: immunofluorescence stathmokinetic studies of the proliferation of cytoplasmic mu-chain-bearing cells in normal mice,” J. Immunol. 131(December 1983):2635-2640.

5337. J.R. Watkins, M.R. Loken, K.L. Knight, “Two B-cell subpopulations identified by flow cytometry,” Immunology 56(October 1985):315-320.

5338. M.L. Jelachich, E.K. Lakey, L. Casten, S.K. Pierce, “Antigen presentation is a function of all B cell subpopulations separated on the basis of size,” Eur. J. Immunol. 16(April 1986):411-416.

5339. Y.H. Park, D.G. Osmond, “Phenotype and proliferation of early B lymphocyte precursor cells in mouse bone marrow,” J. Exp. Med. 165(1 February 1987):444-458.

5340. T. Jakob, M.C. Udey, “Epidermal Langerhans cells: from neurons to nature’s adjuvants,” Adv. Dermatol. 14(1999):209-258, 259 (discussion).

5341. L. Pieri, L. Domenici, P. Romagnoli, “Langerhans cells differentiation: a three-act play,” Ital. J. Anat. Embryol. 106(January-March 2001):47-69.

5342. N. Romani, G. Ratzinger, K. Pfaller, W. Salvenmoser, H. Stossel, F. Koch, P. Stoitzner, “Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance,” Int. Rev. Cytol. 207(2001):237-270.

5343. S.V. Petersen, S. Thiel, J.C. Jensenius, “The mannan-binding lectin pathway of complement activation: biology and disease association,” Mol. Immunol. 38(August 2001):133-149; M. Gadjeva, S. Thiel, J.C. Jensenius, “The mannan-binding-lectin pathway of the innate immune response,” Curr. Opin. Immunol. 13(February 2001):74-78.

5344. Charles D. Collard, Antti Vakeva, Margaret A. Morrissey, Azin Agah, Scott A. Rollins, Wende R. Reenstra, Jon A. Buras, Seppo Meri, Gregory L. Stahl, “Complement activation after oxidative stress: role of the lectin complement pathway,” Am. J. Pathol. 156(May 2000):1549-1556; http://ajp.amjpathol.org/cgi/content/full/156/5/1549

5345. S.V. Petersen, S. Thiel, L. Jensen, T. Vorup-Jensen, C. Koch, J.C. Jensenius, “Control of the classical and the MBL pathway of complement activation,” Mol. Immunol. 37(October 2000):803-811.

5346. R. Lekowski, C.D. Collard, W.R. Reenstra, G.L. Stahl, “Ulex europaeus agglutinin II (UEA-II) is a novel, potent inhibitor of complement activation,” Protein Sci. 10(February 2001):277-284.

5347. H. Zhao, N. Wakamiya, Y. Suzuki, M.T. Hamonko, G.L. Stahl, “Identification of human mannose binding lectin (MBL) recognition sites for novel inhibitory antibodies,” Hybrid. Hybridomics 21(February 2002):25-36.

5348. S.S. Asghar, M.C. Pasch, “Therapeutic inhibition of the complement system. Y2K update,” Front. Biosci. 5(1 September 2000):E63-E81.

5349. B.H. Devens, D.R. Webb, “Phenotypic identification of specific and nonspecific suppressor T-cell populations involved in the in vivo response to alloantigen,” Cell Immunol. 161(March 1995):1-7.

5350. R.M. O’Hara Jr., M.C. Byrne, V.K. Kuchroo, A. Nagelin, M.J. Whitters, S. Jayaraman, S.L. Henderson, M.E. Dorf, M. Collins, “T cell receptor alpha-chain defines the antigen specificity of antigen-specific suppressor factor but does not impart genetic restriction,” J. Immunol. 154(1 March 1995):2075-2081.

5351. H.L. Hu, W.D. Cornwell, T.J. Rogers, Y.S. Lin, “In vivo analysis of a superantigen-induced T cell suppressor factor,” Cell Immunol. 167(1 February 1996):285-292.

5352. A.I. Colovai, Z. Liu, R. Ciubotariu, S. Lederman, R. Cortesini, N. Suciu-Foca, “Induction of xenoreactive CD4+ T-cell anergy by suppressor CD8+CD28- T cells,” Transplantation 69(15 April 2000):1304-1310, 1233-1234 (comment).

5353. R. Cortesini, J. LeMaoult, R. Ciubotariu, N.S. Cortesini, “CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity,” Immunol. Rev. 182(August 2001):201-206.

5354. C.C. Chang, R. Ciubotariu, J.S. Manavalan, J. Yuan, A.I. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, N. Suciu-Foca, “Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4,” Nat. Immunol. 3(March 2002):237-243, 215-217 (comment).

5355. Y. Kaneda, “Virosomes: evolution of the liposome as a targeted drug delivery system,” Adv. Drug Deliv. Rev. 43(30 September 2000):197-205.

5356. J.O. Oh, “Immunology of viral infections,” Int. Ophthalmol. Clin. 25(Summer 1985):107-116.

5357. F. Kronenberg, “Hot flashes: phenomenology, quality of life, and search for treatment options,” Exp. Gerontol. 29(May-August 1994):319-336.

5358. G.A. Bachmann, “Vasomotor flushes in menopausal women,” Am. J. Obstet. Gynecol. 180(March 1999):S312-S316.

5359. C.L. Loprinzi, K.M. Zahasky, J.A. Sloan, P.J. Novotny, S.K. Quella, “Tamoxifen-induced hot flashes,” Clin. Breast Cancer 1(April 2000):52-56.

5360. H.H. Berendsen, “The role of serotonin in hot flushes,” Maturitas 36(31 October 2000):155-164.

5361. R.R. Freedman, “Physiology of hot flashes,” Am. J. Human Biol. 13(July-August 2001):453-464; “Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes,” Fertil. Steril. 70(August 1998):332-337.

5362. C Sixty, Inc.; http://www.csixty.com

5363. C.D. Hewitt, J. Savory, M.R. Wills, “Aspects of aluminum toxicity,” Clin. Lab. Med. 10(June 1990):403-422.

5364. S. Chan, B. Gerson, “Technical aspects of quantification of aluminum,” Clin. Lab. Med. 10(June 1990):423-433.

5365. A.B. Hodsman, B.M. Steer, “Serum aluminum levels as a reflection of renal osteodystrophy status and bone surface aluminum staining,” J. Am. Soc. Nephrol. 2(February 1992):1318-1327.

5366. A.T. Kausz, J.E. Antonsen, G. Hercz, Y. Pei, N.S. Weiss, S. Emerson, D.J. Sherrard, “Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients,” Am. J. Kidney Dis. 34(October 1999):688-693.

5367. K.H. Shin, H. Nakagawa, S. Tsurufuji, “Inhibition by hydroxyurea of the rebound of granulomatous inflammation following withdrawal of glucocorticoid therapy,” Jpn. J. Pharmacol. 25(February 1975):76-79.

5368. R.W. Schroff Jr., E.R. Heise, Q.N. Myrvik, B.T. Shannon, “Selective suppression of granuloma formation and delayed hypersensitivity in rabbits,” Infect. Immun. 28(April 1980):269-276.

5369. K. Yamamoto, D.L. Granger, W. Brehmer, I. Azuma, E. Ribi, “Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis,” Zentralbl. Bakteriol. Mikrobiol. Hyg. A 250(1981):127-141.

5370. L.C. McIntosh, R.G. Pugh-Humphreys, R.A. Fraser, A.W. Thomson, “Inhibition by the Landschutz ascites carcinoma of the granulomatous inflammatory response to C. parvum,” Br. J. Cancer 45(April 1982):598-612.

5371. S. Kyuwa, K. Fujiwara, K. Ueda, “Suppression of BCG granuloma formation in mice by sensitized splenic lymphocytes,” Jpn. J. Exp. Med. 53(February 1983):69-72.

5372. M. Kimura, S. Kobayashi, B. Luo, I. Kimura, “Selective inhibition by magnosalin and magnoshinin, compounds from ‘shin-i’ (Flos magnoliae), of adjuvant-induced angiogenesis and granuloma formation in the mouse pouch,” Int. Arch. Allergy Appl. Immunol. 93(1990):365-370.

5373. A.M. Goes, S.A. Rezende, G. Gazzinelli, B.L. Doughty, “Granulomatous hypersensitivity to Schistosoma mansoni EGG antigens in human schistosomiasis. IV. A role for prostaglandin-induced inhibition of in vitro granuloma formation,” Parasite Immunol. 16(January 1994):11-18.

5374. G.F. Webster, S.M. Toso, L. Hegemann, “Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C,” Arch. Dermatol. 130(June 1994):748-752.

5375. M. Isaji, N. Aruga, J. Naito, H. Miyata, “Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro,” Life Sci. 55(1994):PL287-PL292.

5376. Antoni Stadnicki, R. Balfour Sartor, Ram Janardham, Abraham Majluf-Cruz, Charles A. Kettner, Albert A. Adam, Robert W. Colman, “Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats,” FASEB J. 12(March 1998):325-333; http://www.fasebj.org/cgi/content/full/12/3/325

5377. A.M. Blum, A. Metwali, M. Kim-Miller, J. Li, K. Qadir, D.E. Elliott, B. Lu, Z. Fabry, N. Gerard, J.V. Weinstock, “The substance P receptor is necessary for a normal granulomatous response in murine schistosomiasis mansoni,” J. Immunol. 162(15 May 1999):6080-6085; http://www.jimmunol.org/cgi/content/full/162/10/6080

5378. M.G. Chiaramonte, D.D. Donaldson, A.W. Cheever, T.A. Wynn, “An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response,” J. Clin. Invest. 104(September 1999):777-785; http://www.jci.org/cgi/content/full/104/6/777

5379. J.B. Sun, M.J. Stadecker, N. Mielcarek, M. Lakew, B.L. Li, H.J. Hernandez, C. Czerkinsky, J. Holmgren, “Nasal administration of Schistosoma mansoni egg antigen-cholera B subunit conjugate suppresses hepatic granuloma formation and reduces mortality in S. mansoni-infected mice,” Scand. J. Immunol. 54(November 2001):440-447.

5380. T. Vomel, N. Muller, D. Platt, “Phagocytosis of erythrocyte membranes (white ghosts) from different species by the isolated perfused rat liver,” Vet. Immunol. Immunopathol. 9(July 1985):273-282.

5381. O.S. Atwal, K.A. Saldanha, “Erythrophagocytosis in alveolar capillaries of goat lung: ultrastructural properties of blood monocytes,” Acta Anat. (Basel) 124(1985):245-254.

5382. R. Green, “Red cell ghost-entrapped deferoxamine as a model clinical targeted delivery system for iron chelators and other compounds,” Bibl. Haematol. 51(1985):25-35.

5383. H. Ueno, A. Tamai, K. Iyota, T. Moriki, “Electron microscopic observation of the cells floating in the anterior chamber in a case of phacolytic glaucoma,” Jpn. J. Ophthalmol. 33(1989):103-113.

5384. L.M. Commins, D.J. Loegering, P.W. Gudewicz, “Effect of phagocytosis of erythrocytes and erythrocyte ghosts on macrophage phagocytic function and hydrogen peroxide production,” Inflammation 14(December 1990):705-716.

5385. M.L. Elgart, “Scabies,” Dermatol. Clin. 8(April 1990):253-263; D.J. Kemp, S.F. Walton, P. Harumal, B.J. Currie, “The scourge of scabies,” Biologist (London) 49(February 2002):19-24; E. Chouela, A. Abeldano, G. Pellerano, M.I. Hernandez, “Diagnosis and treatment of scabies: a practical guide,” Am. J. Clin. Dermatol. 3(2002):9-18.

5386. M.V. Dahl, “The immunology of scabies,” Ann. Allergy 51(December 1983):560-566.

5387. R.R. Dalton, J.S. Krauss, D.G. Falls, G.K. Fuller, “Clinical commentary: granulocytic fragments in sepsis,” Ann. Clin. Lab. Sci. 31(October 2001):365-368.

5388. D. Vittori, A. Nesse, G. Perez, G. Garbossa, “Morphologic and functional alterations of erythroid cells induced by long-term ingestion of aluminium,” J. Inorg. Biochem. 76(30 August 1999):113-120.

5389. S. Mansoor, A. Roman, R. Weinstein, “Intravascular stents do not cause microangiopathic hemolysis or thrombotic microangiopathy,” J. Clin. Apheresis 14(1999):130-134.

5390. G. Ismeno, A. Renzulli, A. Carozza, M. De Feo, M. Iannuzzi, P. Sante, M. Cotrufo, “Intravascular hemolysis after mitral and aortic valve replacement with different types of mechanical prostheses,” Int. J. Cardiol. 69(15 May 1999):179-183; M. Ninomiya, K. Yagyu, Y. Kaneko, Y. Kotsuka, S. Takamoto, “Hemolysis after mitral valve replacement with mechanical valve prostheses,” Jpn. J. Thorac. Cardiovasc. Surg. 49(April 2001):230-235.

5391. G. Mecozzi, A.D. Milano, M. De Carlo, F. Sorrentino, S. Pratali, C. Nardi, U. Bortolotti, “Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study,” J. Thorac. Cardiovasc. Surg. 123(March 2002):550-556.

5392. R.A. Asherson, R. Cervera, J.C. Piette, J. Font, J.T. Lie, A. Burcoglu, K. Lim, F.J. Munoz-Rodriguez, R.A. Levy, F. Boue, J. Rossert, M. Ingelmo, “Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients,” Medicine (Baltimore) 77(May 1998):195-207.

5393. D.G. Batton, A. Amanullah, C. Comstock, “Fetal schistocytic hemolytic anemia and umbilical vein varix,” J. Pediatr. Hematol. Oncol. 22(May-June 2000):259-261.

5394. T. Yasuda, A. Funakubo, Y. Fukui, “An investigation of blood damage induced by static pressure during shear-rate conditions,” Artif. Organs 26(January 2002):27-31; T. Yasuda, A. Funakubo, F. Miyawaki, T. Kawamura, T. Higami, Y. Fukui, “Influence of static pressure and shear rate on hemolysis of red blood cells,” ASAIO J. 47(July-August 2001):351-353.

5395. Y. Shapira, O. Bairey, M. Vatury, H. Magen-Nativ, M. Prokocimer, A. Sagie, “Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: case reports and literature review,” J. Heart Valve Dis. 10(July 2001):431-435.

5396. M.W. Miller, A.A. Brayman, T.A. Sherman, J.S. Abramowicz, C. Cox, “Comparative sensitivity of human fetal and adult erythrocytes to hemolysis by pulsed 1 MHz ultrasound,” Ultrasound Med. Biol. 27(March 2001):419-425.

5397. A. Usui, Y. Takagi, Y. Ohara, O. Kawaguchi, T. Watanabe, Y. Ueda, “Sarpogrelate reduces mechanical hemolysis in patients with heart valve prostheses,” Jpn. J. Thorac. Cardiovasc. Surg. 48(December 2000):769-774; A. Sabo, M. Stanulovic, V. Jakovljevic, “Phytomenadione improves red cell deformability in laboratory animals,” Int. J. Clin. Pharmacol. Ther. Toxicol. 30(December 1992):587-590.

5398. S.C. Liu, L.H. Derick, P. Agre, J. Palek, “Alteration of the erythrocyte membrane skeletal ultrastructure in hereditary spherocytosis, hereditary elliptocytosis, and pyropoikilocytosis,” Blood 76(1 July 1990):198-205.

5399. J. Delaunay, N. Alloisio, L. Morle, F. Baklouti, N. Dalla Venezia, P. Maillet, R. Wilmotte, “Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis,” Ann. Genet. 39(1996):209-221.

Last updated on 16 April 2004